NAVIDEA BIOPHARMACEUTICALS, INC. Annual Income Tax Expense (Benefit) in USD from 2010 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Navidea Biopharmaceuticals, Inc. annual/quarterly Income Tax Expense (Benefit) history and growth rate from 2010 to 2022.
  • Navidea Biopharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2022 was $0.000, a 100% decline year-over-year.
  • Navidea Biopharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000, a 100% decline from 2021.
  • Navidea Biopharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2021 was $16K.
  • Navidea Biopharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2020 was $0.000, a 100% decline from 2019.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $0 -$16K -100% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-27
2021 $16K +$16K Jan 1, 2021 Dec 31, 2021 10-K 2023-03-27
2020 $0 -$707 -100% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
2019 $707 +$10.5K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-26
2018 -$9.75K +$4.05M +99.8% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-18
2017 -$4.06M -$4.06M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-15
2016 $0 +$436K Jan 1, 2016 Dec 31, 2016 10-K 2017-03-31
2015 -$436K -$436K Jan 1, 2015 Dec 31, 2015 10-K 2017-03-31
2014 $0 $0 Jan 1, 2014 Dec 31, 2014 10-K 2017-03-31
2013 $0 $0 Jan 1, 2013 Dec 31, 2013 10-K 2015-03-16
2012 $0 +$7.88M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-16
2011 -$7.88M* -$10M -469% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-14
2010 $2.13M Jan 1, 2010 Dec 31, 2010 10-K/A 2013-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.